Help us: Donate
Follow us on:
×

Menu

Back

Tag: Ichor Therapeutics

November 05, 2020
Buckminsterfullerene, also known as C60, is a remarkable molecule with a range of interesting chemical and physical properties. Several years ago, C60 came to the attention of the longevity community several years ago when a study with a small cohort of rats found that C60 dissolved in olive oil extended their lifespan [1]. This led...
September 25, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Dr. Kelsey Moody gave a detailed presentation on macular degeneration, discussing its origins in the lysosomes and how it progresses...
May 28, 2019
A BIOTECH IN A BOX WORKSHOP Alongside our Ending Age-related Diseases 2019 annual conference, we are proud to announce the launch of a special pre-conference biotech workshop led by Dr. Kelsey Moody, CEO of Ichor Therapeutics, a successful and rapidly growing rejuvenation biotechnology company. This joint event between the Life Extension Advocacy Foundation and Ichor...
April 11, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages of aging and may one day lead to a future without the diseases of aging. We were glad to have the opportunity to conduct a...
February 12, 2019
I recently visited the Longevity Leaders Conference in London and had the opportunity to speak with Kelsey Moody, the CEO of Ichor Therapeutics, a company focused on targeting age-related diseases by targeting the aging processes themselves. I previously interviewed him back in 2017, so it was the ideal time to catch up on what had...
October 17, 2018
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights. Dr. Oliver Medvedik, LEAF vice president and Director of...